Keywords: astrazeneca, reports, strong, results, symbicort, pediatric, trial
AstraZeneca reports strong results in Symbicort pediatric trial
Article | 26 May 2008
Anglo-Swedish drug major AstraZeneca reported positive data for a study evaluating the safety and efficacy of its asthma treatment Symbicort ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
